Haleon Patent Information

Haleon values innovation. The purpose this page is to provide information about Haleon’s innovation. Certain Haleon products and/or their manufacture and/or their use either alone or in combination with other product(s) are protected by patents or subject to pending patent applications in the United States (U.S.) and possibly elsewhere. This website is provided to satisfy the virtual patent marking provisions of the United States, including the virtual patent marking provisions of the America Invents Act and provide notice under 35 U.S.C. §287(a). While every effort is made to ensure completeness, the following list of products and their respective patents or patent applications and this website may not be all inclusive, and is not intended to provide non-U.S. patent information. For example, some products listed here may be covered by patents in the United States and/or elsewhere that are not listed, and other products not listed here may be protected by one or more patents in the United States and/or elsewhere. Thus, the absence of a product or a U.S. Patent number or a U.S. Patent Application number from this website shall not constitute a waiver of Haleon’s patent, or other intellectual property rights concerning that product, its use, or manufacture or patent.

ROBITUSSIN products U.S. Patent(s) & Patent(s) Pending
Robitussin Peak Cold Maximum Strength Multi-Symptom Cold U.S. Pats. 9,308,166; 9,744,133

Updated May 10, 2023